Key statistics
As of last trade ONWARD Medical NV (63E:MUN) traded at 4.09, 9.21% above its 52-week low of 3.75, set on Apr 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.09 |
|---|---|
| High | 4.09 |
| Low | 4.09 |
| Bid | 4.02 |
| Offer | 4.06 |
| Previous close | 4.09 |
| Average volume | 41.14 |
|---|---|
| Shares outstanding | 56.01m |
| Free float | 46.76m |
| P/E (TTM) | -- |
| Market cap | 235.24m EUR |
| EPS (TTM) | -0.866 EUR |
Data delayed at least 15 minutes, as of Mar 02 2026 07:00 GMT.
More ▼
Announcements
- ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
- ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
- ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
- ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
- ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
- ONWARD Medical Publishes Closing of Bookbuild Offering
- ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
- ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
- ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
- Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
More ▼
